Jason R. Niswonger
Known title: SVP, Finance & IRCIK: 0001696709
Jason R. Niswonger's purchase track record
Jason R. Niswonger has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/11/2026 | IBP | $98K | +14.5% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| IBP | ▼ Sell | Gift | 25 | $0 | 5/12/2026 | View on chart |
| IBP | ▲ Buy | Open Market | 455 | $98K | 5/11/2026 | View on chart |
| IBP | ▼ Sell | Tax Withholding | 1,406 | $435K | 4/20/2026 | View on chart |
| IBP | ▲ Buy | Grant | 3,128 | $0 | 2/24/2026 | View on chart |
| IBP | ▲ Buy | Grant | 469 | $0 | 2/24/2026 | View on chart |
| IBP | ▼ Sell | Tax Withholding | 1,596 | $253K | 4/20/2025 | View on chart |
| IBP | ▲ Buy | Grant | 2,329 | $0 | 2/25/2025 | View on chart |
| IBP | ▲ Buy | Grant | 584 | $0 | 2/25/2025 | View on chart |
| IBP | ▼ Sell | Open Market | 1,100 | $254K | 5/13/2024 | View on chart |
| IBP | ▼ Sell | Open Market | 4,900 | $1.1M | 5/13/2024 | View on chart |
| IBP | ▼ Sell | Tax Withholding | 959 | $212K | 4/20/2024 | View on chart |
| IBP | ▲ Buy | Grant | 3,982 | $0 | 2/20/2024 | View on chart |
| IBP | ▼ Sell | Tax Withholding | 6,870 | $837K | 4/20/2023 | View on chart |
| IBP | ▲ Buy | Grant | 3,060 | $0 | 2/20/2023 | View on chart |
| IBP | ▼ Sell | Tax Withholding | 940 | $80K | 4/20/2022 | View on chart |
| IBP | ▲ Buy | Grant | 1,174 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
IBP Shares Fall as RBC Cuts Target and Melius Initiates Hold
Installed Building Products shares dropped alongside other industrial peers, partly due to RBC Capital lowering its price target to $208 and Melius Research initiating coverage with a Hold rating. While the stock is trading near its 52-week low, the average analyst target remains significantly higher at $239.92. The company also released its 2026 ESG report, but the recent focus has been on the mixed analyst outlook.
IBP Shares Fall as RBC Cuts Target and Melius Initiates Hold. Installed Building Products shares dropped alongside other industrial peers, partly due to RBC Capital lowering its price target to $208 and Melius Research initiating coverage with a Hold rating. While the stock is trading near its 52-week low, the average analyst target remains significantly higher at $239.92. The company also released its 2026 ESG report, but the recent focus has been on the mixed analyst outlook.